 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- | merotocin (FE 202767) / Ferring
Journal: No Measurable Transfer of Oxytocin-Receptor Agonist Merotocin Detected in Human Breast Milk. (Pubmed Central) - Jun 17, 2024
There was one moderate event, whereas all the other events were considered mild. Merotocin was undetectable in breast milk after single iv administration of up to 20 ?g in early postpartum women and women with established lactation.
- | merotocin (FE 202767) / Ferring
Enrollment change, Trial completion date, Trial termination, Trial primary completion date: Mermaid: Merotocin in Mothers With Inadequate Milk Production and Infants Delivered Prematurely (clinicaltrials.gov) - Jan 18, 2023
P2, N=4, Terminated, Sponsor: Ferring Pharmaceuticals
N=100 --> 4 | Trial completion date: Oct 2023 --> Nov 2022 | Recruiting --> Terminated | Trial primary completion date: Oct 2023 --> Nov 2022; The trial was prematurely terminated. Termination was not because of safety concerns but due to slow recruitment.
- || merotocin (FE 202767) / Ferring
Trial completion date, Trial primary completion date: Mermaid: Merotocin in Mothers With Inadequate Milk Production and Infants Delivered Prematurely (clinicaltrials.gov) - Mar 2, 2022
P2, N=100, Recruiting, Sponsor: Ferring Pharmaceuticals
Termination was not because of safety concerns but due to slow recruitment. Trial completion date: Oct 2022 --> Sep 2023 | Trial primary completion date: Oct 2022 --> Sep 2023
- || merotocin (FE 202767) / Ferring
Trial completion date, Trial primary completion date: Mermaid: Merotocin in Mothers With Inadequate Milk Production and Infants Delivered Prematurely (clinicaltrials.gov) - Feb 23, 2021
P2, N=100, Not yet recruiting, Sponsor: Ferring Pharmaceuticals
Trial completion date: Oct 2022 --> Sep 2023 | Trial primary completion date: Oct 2022 --> Sep 2023 Trial completion date: Jun 2022 --> Sep 2022 | Trial primary completion date: Jun 2022 --> Sep 2022
- ||| merotocin (FE 202767) / Ferring
Enrollment open: Mermaid: Merotocin in Mothers With Inadequate Milk Production and Infants Delivered Prematurely (clinicaltrials.gov) - Dec 21, 2020
P2, N=100, Recruiting, Sponsor: Ferring Pharmaceuticals
Trial completion date: Jun 2022 --> Sep 2022 | Trial primary completion date: Jun 2022 --> Sep 2022 Not yet recruiting --> Recruiting
- || merotocin (FE 202767) / Ferring
Trial completion date, Trial primary completion date: Mermaid: Merotocin in Mothers With Inadequate Milk Production and Infants Delivered Prematurely (clinicaltrials.gov) - Oct 27, 2020
P2, N=100, Not yet recruiting, Sponsor: Ferring Pharmaceuticals
Not yet recruiting --> Recruiting Trial completion date: Dec 2021 --> May 2022 | Trial primary completion date: Dec 2021 --> May 2022
- || merotocin (FE 202767) / Ferring
Trial completion date, Trial primary completion date: Mermaid: Merotocin in Mothers With Inadequate Milk Production and Infants Delivered Prematurely (clinicaltrials.gov) - Mar 30, 2020
P2, N=100, Not yet recruiting, Sponsor: Ferring Pharmaceuticals
Trial completion date: Dec 2021 --> May 2022 | Trial primary completion date: Dec 2021 --> May 2022 Trial completion date: Apr 2021 --> Dec 2021 | Trial primary completion date: Apr 2021 --> Dec 2021
- || merotocin (FE 202767) / Ferring
Trial completion date, Trial primary completion date: Mermaid: Merotocin in Mothers With Inadequate Milk Production and Infants Delivered Prematurely (clinicaltrials.gov) - Jan 14, 2019
P2, N=100, Not yet recruiting, Sponsor: Ferring Pharmaceuticals
Trial completion date: Apr 2021 --> Dec 2021 | Trial primary completion date: Apr 2021 --> Dec 2021 Trial completion date: Jun 2020 --> Feb 2021 | Trial primary completion date: Jun 2020 --> Feb 2021
- || merotocin (FE 202767) / Ferring
Trial completion date, Trial primary completion date: Mermaid: Merotocin in Mothers With Inadequate Milk Production and Infants Delivered Prematurely (clinicaltrials.gov) - Jun 4, 2018
P2, N=100, Not yet recruiting, Sponsor: Ferring Pharmaceuticals
Trial completion date: Jun 2020 --> Feb 2021 | Trial primary completion date: Jun 2020 --> Feb 2021 Trial completion date: Oct 2019 --> Jun 2020 | Trial primary completion date: Oct 2019 --> Jun 2020
- ||| merotocin (FE 202767) / Ferring
Trial initiation date, Trial primary completion date: Mermaid: Merotocin in Mothers With Inadequate Milk Production and Infants Delivered Prematurely (clinicaltrials.gov) - Oct 16, 2017
P2, N=100, Not yet recruiting, Sponsor: Ferring Pharmaceuticals
Trial completion date: Oct 2019 --> Jun 2020 | Trial primary completion date: Oct 2019 --> Jun 2020 Initiation date: Nov 2017 --> Jun 2018 | Trial primary completion date: Jun 2018 --> Oct 2019
- ||| merotocin (FE 202767) / Ferring
Trial initiation date: Mermaid: Merotocin in Mothers With Inadequate Milk Production and Infants Delivered Prematurely (clinicaltrials.gov) - Apr 12, 2017
P2, N=100, Not yet recruiting, Sponsor: Ferring Pharmaceuticals
Initiation date: Nov 2017 --> Jun 2018 | Trial primary completion date: Jun 2018 --> Oct 2019 Initiation date: Mar 2017 --> Nov 2017
- ||| merotocin (FE 202767) / Ferring
Trial initiation date, Trial primary completion date: Mermaid: Merotocin in Mothers With Inadequate Milk Production and Infants Delivered Prematurely (clinicaltrials.gov) - May 10, 2016
P2, N=100, Not yet recruiting, Sponsor: Ferring Pharmaceuticals
Initiation date: Mar 2017 --> Nov 2017 Initiation date: Dec 2016 --> Mar 2017 | Trial primary completion date: Mar 2018 --> Jun 2018
- ||| merotocin (FE 202767) / Ferring
Trial initiation date, Trial primary completion date: Mermaid: Merotocin in Mothers With Inadequate Milk Production and Infants Delivered Prematurely (clinicaltrials.gov) - Oct 23, 2015
P2, N=100, Not yet recruiting, Sponsor: Ferring Pharmaceuticals
Initiation date: Dec 2016 --> Mar 2017 | Trial primary completion date: Mar 2018 --> Jun 2018 Initiation date: Sep 2015 --> Dec 2016 | Trial primary completion date: Dec 2016 --> Mar 2018
- ||||| merotocin (FE 202767) / Ferring
New P2 trial: Mermaid: Merotocin in Mothers With Inadequate Milk Production and Infants Delivered Prematurely (clinicaltrials.gov) - Sep 9, 2015
P2, N=100, Not yet recruiting, Sponsor: Ferring Pharmaceuticals